First granted example of novel FDA trial design under Expedited Access Pathway for premarket approval: BeAT-HF (Q91005664)
Jump to navigation
Jump to search
scientific article published on 22 July 2018
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | First granted example of novel FDA trial design under Expedited Access Pathway for premarket approval: BeAT-HF |
scientific article published on 22 July 2018 |
Statements
First granted example of novel FDA trial design under Expedited Access Pathway for premarket approval: BeAT-HF (English)
JoAnn Lindenfeld
Fred A Weaver
Faiez Zannad
Todd Graves
Tyson Rogers
Elizabeth G Galle